Showing results (6381-6390 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|July 12, 2016
Design and Synthesis of 2-(Arylmethylideneamino) Isoindolines as New Potential Analgesic and Anti-Inflammatory Agents: A Molecular Hybridization ApproachMaryam Iman, Hamed Shafaroodi, Asghar Davood, et al.Current Pharmaceutical Design|July 26, 2017
Effects of Oral and Non-Insulin Injectable Antidiabetic Treatment in Hypertension: A Systematic ReviewVasiliki Katsi, Georgios Georgiopoulos, Georgia Vogiatzi, et al.Current Pharmaceutical Design|July 27, 2017
MiRNA-based Therapeutic Strategy in Lung CancerGuang Li, Jing Fang, Ying Wang, et al.Current Pharmaceutical Design|August 8, 2017
The Relevance of Post-Transcriptional Mechanisms in HIV Latency ReversalAmbra Sarracino, Alessandro MarcelloCurrent Pharmaceutical Design|June 6, 2016
Discriminating Drug-Like Compounds by Partition Trees with Quantum Similarity Indices and Graph InvariantsJesus V de Julián-Ortiz, Rafael Gozalbes, Emili BesalúCurrent Pharmaceutical Design|July 1, 2016
Development of a Mouse Model of Shiga Toxin 2 (Stx2) Intoxication for Testing Therapeutic Agents Against Hemolytic Uremic Syndrome (HUS)Maria Pilar Mejias, Romina Jimena Fernandez-Brando, Maria Victoria Ramos, et al.Current Pharmaceutical Design|July 18, 2017
GSK3 Inhibitors in the Therapeutic Development of Diabetes, Cancer and Neurodegeneration: Past, Present and FutureMudasir Maqbool, Nasimul HodaCurrent Pharmaceutical Design|July 18, 2017
Current and Emerging Strategies in Osteoporosis ManagementStefka Ivanova, Liliya VasilevaCurrent Pharmaceutical Design|July 18, 2017
Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol TransporterJi-Young Cha, Jong-Min Park, Ho-Jae Lee, et al.Current Pharmaceutical Design|July 18, 2017
Management of Blood Pressure and Heart Rate in Patients with Acute StrokeCarlo Maida, Antonino Tuttolomondo, Domenico Di Raimondo, et al.Pageof 1,008